Skip to main content
OpenTrials
Recruiting

NCT Number: NCT01619917

The Role of Fractional Vascular Laser Therapy in the Management of Burn Scars

While the literature tends to support the use of laser therapy in the management of burn scars, there is a definite lack of appropriately powered, randomized controlled trials. Laser therapy can be quite expensive when compared to other treatment modalities for burn scars, and while promising, its true usefulness has yet to be conclusively demonstrated. For this reason, our assessing the effects of fractional vascular lasers on burn scars. It has been hypothesized that the fractional vascular lasers work on mature scars to decrease scar formation, and the fractional laser works on scar that is quiescent to promote remodelling. The retexturing/ resurfacing of the laser theoretically can decrease the visibility of the mesh pattern created by meshed split thickness skin graft).

Objective:

To determine the benefit of fractional vascular laser treatment in improving burn scar height, texture, vascularity and pliability in late burn scars.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Manitoba

Winnipeg, Manitoba, R3A 1R9, Canada

Location status: Recruiting

Location contact

Justin P Gawaziuk, MSc

CONTACT

[email protected]

2047873669

Sarvesh Logsetty, MD

PRINCIPAL_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • living in Winnipeg
  • burn scar 6-12 months old
  • Fitzpatrick skin type I-III
  • thermal burn scar on trunk or extremities

Exclusion criteria

  • open wound

Treatment and study plan

Fractional Vascular Laser

Device

laser energy will be applied to one of 2 sites (proximal or distal) depending on randomization result

Primary outcomes

  1. reduction in scar appearance

    Time frame: every 3 weeks to 15 weeks

    examine with modified Vancouver Scar Scale

Study contacts

Contact information is provided by the study sponsor or research team.

Justin Gawaziuk, MSc

CONTACT

[email protected]

2047893669

Sponsors and collaborators

Lead sponsor

University of Manitoba

Other

Registry information

Important dates

Study start
2012
Primary completion
2028
Study completion
2028
First posted
Jun 14, 2012
Registry last updated
May 14, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.